Tandem cycle high-dose chemotherapy (HDCT) of melphalan (MEL) and busulfan/cyclophosphamide (BU/CY) with peripheral blood progenitor cell rescue (PBPC) in multiple myeloma (MM).

被引：0

作者：

Somlo, G ^{[1
]}

Snyder, D ^{[1
]}

Brown, A ^{[1
]}

Dagis, A ^{[1
]}

Nademanee, A ^{[1
]}

ODonnell, M ^{[1
]}

Parker, P ^{[1
]}

Stein, A ^{[1
]}

Smith, E ^{[1
]}

Molina, A ^{[1
]}

Spielberger, R ^{[1
]}

Margolin, K ^{[1
]}

Planas, I ^{[1
]}

Kashyap, A ^{[1
]}

Chow, W ^{[1
]}

Fung, H ^{[1
]}

Bhatia, R ^{[1
]}

Forman, SJ ^{[1
]}

机构：

[1] CITY HOPE NATL MED CTR,DUARTE,CA 91010

来源：

BLOOD | 1997年 / 90卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1709 / 1709

页数：1

共 50 条

[31] High-Dose Gemcitabine Combined With Busulfan and Melphalan (Gem/Bu/Mel) With Autologous Stem-Cell Transplant (ASCT) In Refractory and Relapsed Myeloma
Nieto, Yago
Shah, Nina
Popat, Uday R.
Jones, Roy B.
Bashir, Qaiser
Bassett, Rolland
Valdez, Benigno C.
Andersson, Bone S.
Parmar, Simrit
Orlowski, Robert Z.
Shah, Jatin J.
Thomas, Sheeba K.
Wang, Michael
Champlin, Richard E.
Qazilbash, Muzaffar
BLOOD, 2013, 122 (21)
[32] High-Dose Melphalan Versus Busulfan, Cyclophosphamide As Conditioning Regimens for Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma
Styler, Michael
Crilley, Pamela Ann
Jain, Maneesh
Ward, Kristine
Topolsky, David
Cho, David
Kim, Marc
BLOOD, 2015, 126 (23)
[33] Comparison of high-dose melphalan with a more intensive regimen of thiotepa, busulfan, and cyclophosphamide for patients with multiple myeloma
Anagnostopoulos, A
Aleman, A
Ayers, G
Donato, M
Champlin, R
Weber, D
Alexanian, R
Giralt, S
CANCER, 2004, 100 (12) : 2607 - 2612
[34] Predictors for successful PBPC harvest following high-dose cyclophosphamide (HD-CY) and G-CSF in patients with multiple myeloma (MM)
Hegenbart, U
Goldschmidt, H
Wallmeier, M
Haas, R
Hunstein, W
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1133 - 1133
[35] HIGH-DOSE CHEMOTHERAPY (HDC) WITH PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) SUPPORT IN THE OUTPATIENT SETTING
MICHELSON, GC
GRINBLATT, D
BYRNEMALLOY, R
ZIMMERMAN, T
WILLIAMS, SF
CLINICAL RESEARCH, 1994, 42 (03): : A378 - A378
[36] Tandem-cycle high-dose melphalan and cisplatin with peripheral blood progenitor cell support in patients with breast cancer and other malignancies
Somlo, G
Chow, W
Hamasaki, V
Leong, L
Margolin, K
Morgan, R
Sniecinski, I
Frankel, P
Reardon, D
Longmate, J
Raschko, J
Shibata, S
O'Donnell, M
Smith, E
Tetef, M
Forman, S
Yen, Y
Molina, A
Doroshow, JH
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2001, 7 (05) : 284 - 293
[37] HIGH-DOSE MELPHALAN, CYCLOPHOSPHAMIDE, AND TOTAL-BODY IRRADIATION FOLLOWED BY PERIPHERAL-BLOOD STEM-CELL RESCUE IN REFRACTORY AND RELAPSING MULTIPLE-MYELOMA
GERTZ, MA
PINEDA, AA
CHEN, MG
LETENDRE, L
GREIPP, PR
SOLBERG, LA
WITZIG, TE
GARTON, JP
INWARDS, DJ
LITZOW, MR
TEFFERI, A
KYLE, RA
NOEL, P
CLINICAL RESEARCH, 1993, 41 (03): : A647 - A647
[38] High-dose chemotherapy with busulfan and cyclophosphamide and autologous stem cell rescue in patients with Hodgkin lymphoma
Lane, Andrew A.
Mcafee, Steven L.
Kennedy, Joanne
Dube, Christine
Attar, Eyal C.
Ballen, Karen K.
Dey, Bimalangshu R.
Spitzer, Thomas R.
Chen, Yi-Bin
LEUKEMIA & LYMPHOMA, 2011, 52 (07) : 1363 - 1366
[39] Neutropenic infections in patients treated with beam high-dose chemotherapy (HDCT) and peripheral blood progenitor cell transplant (PBPCT).
Seropian, S
Nadkarni, R
Jillella, AP
Salloum, E
Hu, GL
Zelterman, D
Cooper, DL
BLOOD, 1997, 90 (10) : 4435 - 4435
[40] High-dose chemotherapy with sequential double cycles of cyclophosphamide and melphalan in patients with multiple myeloma.
Nowrousian, MR
Wrzeciono, T
Tewes, M
Fossa, A
Welt, A
Schuett, P
Brandhorst, D
Kloke, O
Schuette, J
Seeber, S
BLOOD, 2000, 96 (11) : 421A - 421A

← 1 2 3 4 5 →